UBS Bets on Target's $2B Turnaround Plan for 2026 Outlook
UBS analysts view Target's planned $2 billion investment for 2026 as a bold, two-pronged turnaround bet. The plan spl...
Equities
On this Equities tag page, you'll find 4 articles covering earnings signals, top performing stocks, stake moves, and auto manufacturers. Read to sharpen your investment strategy and stay updated.
74 articlesBiel: Salesforce’s Transaction Data Shields Its Edge
A Biel note argues that biel: salesforce’s transaction data creates a durable moat for Salesforce, tying revenue to a...
Wall Street’s $138.56 Price Targets United Airlines Selloff
United Airlines faces near term pressure from higher fuel costs, yet the Street remains optimistic with a consensus t...
Retail Investors Showing Signs of Fatigue as Iran Risks Grow
JPMorgan warns that retail investors showing signs of fatigue could temper stock demand as Iran-related tensions inte...
Retirees Use EWY’s Surge to Bet on AI Chip Revival
EWY has surged in 2026 on AI-driven demand for memory chips, attracting a growing cohort of retirees into the play. T...
Intel Corp (INTC) Stock Outlook for 2026, 2027 and 2030
Intel faces a turning point as AI-driven demand and ramping foundry capacity shape intel corp (intc) stock. Analysts ...
Oracle Price Target $240 Sparks AI Cloud Rally Today
Analysts raise the oracle price target $240 after Oracle reports resilient AI cloud demand and stronger-than-expected...
AMAT and MICRON Still Winning in the AI Trade Today
Applied Materials and Micron defy a broader market lull, driven by persistent AI memory demand and a healthy equipmen...
Software Stocks Sector Shows Fresh Life, Analysts Say Today
Software stocks are rebounding as growth signals improve and enterprise demand remains resilient. Analysts warn that ...
Short Sellers Betting Against Intel Intensifies in Dow
Intel remains the Dow's most shorted stock as fresh data show rising short interest amid continued cash burn in the f...
Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Wall Street Pulls Back on Novo Nordisk and Jefferies
Stocks retreat as Novo Nordisk and Jefferies face analyst downgrades, while Talkspace advances toward a private-equit...